Comorbidities Clinical Trial
Official title:
It is Possible to Continuous Monitor Vital Signs in Patients Discharged a Rehabilitation Center - An Observational Feasibility Study
Verified date | May 2022 |
Source | Rigshospitalet, Denmark |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Some patients unable to return home from hospital due to physical or mental illness will be discharged to a rehabilitation home to restore strength and rehabilitate. This study attempts to examine if it is possible to continuously monitor the vital signs in patients discharged to a rehabilitation center and whether wearable devices will detect more abnormal vital signs than the rehabilitation facility, as well as complication and readmission rates.
Status | Completed |
Enrollment | 20 |
Est. completion date | October 8, 2021 |
Est. primary completion date | September 8, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 110 Years |
Eligibility | Inclusion Criteria: - discharged to the rehabilitation center after surgery or; diagnosed with ischemic heart disease, chronic heart disease, apoplexia cerebri, chronic obstructive pulmonary disease, or diabetes. - Inclusion less than 72 h from rehabilitation admission Exclusion Criteria: - Unable to give informed consent - Implanted pacemaker or cardioverter-defibrillator - allergic to plaster, plastic, silicone |
Country | Name | City | State |
---|---|---|---|
Denmark | Center for Rehabilitering og Akutpleje - Bystævneparken | Brønshøj |
Lead Sponsor | Collaborator |
---|---|
Rigshospitalet, Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Complication | Complication frequency within 30 days from study inclusion | 30 days | |
Other | Readmission | Readmission frequency within 30 days from study inclusion | 30 days | |
Primary | Monitoring time | Monitoring time with data from any device | 96 hours | |
Secondary | SpO2 < 92% | Duration of SpO2 < 92% | 96 hours | |
Secondary | SpO2 < 88% | Duration of SpO2 < 88% | 96 hours | |
Secondary | SpO2 < 85% | Duration of SpO2 < 85% | 96 hours | |
Secondary | SpO2 < 80% | Duration of SpO2 < 80% | 96 hours | |
Secondary | Respiratory rate <5 breaths per minute | Duration of respiratory rate <5 breaths per minute | 96 hours | |
Secondary | Respiratory rate <11 breaths per minute | Duration of respiratory rate <11 breaths per minute | 96 hours | |
Secondary | Respiratory rate >24 breaths per minute | Duration of respiratory rate >24 breaths per minute | 96 hours | |
Secondary | Respiratory rate >30 breaths per minute | Duration of respiratory rate >30 breaths per minute | 96 hours | |
Secondary | Heart rate <30 beats per minute | Duration of heart rate <30 beats per minute | 96 hours | |
Secondary | Heart rate <40 beats per minute | Duration of heart rate <40 beats per minute | 96 hours | |
Secondary | Heart rate > 110 beats per minute | Duration of heart rate > 110 beats per minute | 96 hours | |
Secondary | Heart rate > 130 beats per minute | Duration of heart rate > 130 beats per minute | 96 hours | |
Secondary | Systolic blood pressure <70 mmHg | Number of systolic blood pressure <70 mmHg measurements | 96 hours | |
Secondary | Systolic blood pressure <90 mmHg | Number of systolic blood pressure <90 mmHg measurements | 96 hours | |
Secondary | Systolic blood pressure >180 mmHg | Number of systolic blood pressure >180 mmHg measurements | 96 hours | |
Secondary | Systolic blood pressure >220 mmHg | Number of systolic blood pressure >220 mmHg measurements | 96 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03434626 -
Advance Care Planning & Goals of Care Randomized Controlled Trial in Primary Care
|
N/A | |
Completed |
NCT04409197 -
Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network
|
||
Recruiting |
NCT04748770 -
Access to Kidney Transplant of Obese Patients Beginning Dialysis
|
||
Recruiting |
NCT02880059 -
Incidence and Effects of Sleep Apnea on Intracerebral Aneurysms
|
N/A | |
Active, not recruiting |
NCT04087239 -
The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study
|
||
Completed |
NCT04109001 -
Method of Measuring Comorbidity to Predict Outcome After Intensive Care
|
||
Completed |
NCT03348449 -
Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi)
|